This paper undertakes a review of available studies to provide a perspective on the role of intellectual property (IP) protection in developing health care innovations in India. The relevant literature in the context of India has followed two strands: some studies focus on the implications of the new IP regime on access to health care, while others explore the implications of IP on innovation in general and medical innovation in particular. We argue that while it is not possible to attribute all types of innovations to changes in the IP regime, there is merit in viewing health care access and innovation as complementary and not dichotomous processes. We explore this relationship by discussing innovations undertaken by the Indian pharmaceutical industry and in health policy to balance the twin goals of invention and affordable health care.
No takes yet. Share an insight, caveat, or question.
Basant et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: